vimarsana.com

Page 182 - ஃப்ரெட் ஹட்சின்சன் புற்றுநோய் ஆராய்ச்சி மையம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

UK COVID-19 variant may be more deadly, prime minister says

UK COVID-19 variant ‘may be’ more deadly, prime minister says By Catherine Park What to know about the new COVID-19 variant from the UK Experts say current COVID-19 vaccines will likely work on the new variant of the coronavirus in the United Kingdom, but are working to confirm that with additional testing. There is emerging evidence to suggest that the recently discovered, highly transmissible COVID-19 variant first reported in the United Kingdom is potentially more deadly, British Prime Minister Boris Johnson said. Since the beginning of this pandemic, we’ve tried to update you as soon as possible about changes in the scientific data or the analysis, Johnson said. So I must tell you this afternoon that we’ve been informed today that in addition to spreading more quickly, it also now appears that there is some evidence that the new variant, the variant that was first identified in London and the southeast, may be associated with a higher degree of mortality.

Scientists find 2 species of human coronavirus that can evolve to evade immune system

Scientists find 2 species of human coronavirus that can evolve to evade immune system January 21, 2021 × The findings suggest that if SARS-CoV-2 evolves in the same way, current vaccines against the virus may become outdated A new study has found that two species of seasonal human coronavirus related to SARS-CoV-2 can evolve in certain proteins to evade recognition by the immune system. The findings of the study, published in the journal eLife, suggested that if SARS-CoV-2 evolves in the same way, current vaccines against the virus may become outdated, requiring new ones to be made to match future strains. The researchers mentioned that the immune system relies on being able to ‘remember’ the antigens that relate to a specific virus in order to provide immunity against it.

Emerging Coronavirus Variants May Pose Challenges to Vaccines

Washington state public health experts cautiously optimistic about Biden s vaccination plan

En ensayos recibieron el placebo; ahora esperan recibir la vacuna real de Pfizer y Moderna

En ensayos recibieron el placebo; ahora esperan recibir la vacuna real de Pfizer y Moderna Judy Peres, Chicago Tribune © Go Nakamura/Getty Images North America/TNS Un trabajador de la salud recibe la vacuna Moderna COVID-19 en el United Memorial Medical Center el 21 de diciembre de 2020, en Houston, Texas. Good news for tens of thousands of volunteers in the COVID-19 vaccine trials: Many of those who received a placebo are now being offered a vaccine in some cases, earlier than they would otherwise have been eligible. Participants in Pfizer’s vaccine study some of whom had mounted a noisy campaign on social media have been advised that anyone who wants one can receive the first of two shots by March 1. Participants in Moderna’s vaccine trial are already getting immunized.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.